XORTX Therapeutics Balance Sheet Health
Financial Health criteria checks 4/6
XORTX Therapeutics has a total shareholder equity of $2.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $6.1M and $3.6M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$3.84m |
| Equity | US$2.49m |
| Total liabilities | US$3.56m |
| Total assets | US$6.05m |
Financial Position Analysis
Short Term Liabilities: XRTX's short term assets ($4.7M) exceed its short term liabilities ($340.9K).
Long Term Liabilities: XRTX's short term assets ($4.7M) exceed its long term liabilities ($3.2M).
Debt to Equity History and Analysis
Debt Level: XRTX is debt free.
Reducing Debt: XRTX has no debt compared to 5 years ago when its debt to equity ratio was 27.8%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: XRTX has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: XRTX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 45.1% each year